Reuters logo
BRIEF-Cumberland Pharmaceuticals reports q1 adjusted EPS $0.02
May 15, 2017 / 8:23 PM / in 5 months

BRIEF-Cumberland Pharmaceuticals reports q1 adjusted EPS $0.02

May 15 (Reuters) - Cumberland Pharmaceuticals Inc

* Cumberland pharmaceuticals reports revenue growth of 25% in first quarter 2017

* Q1 revenue $9.6 million versus $7.7 million

* Q1 adjusted earnings per share $0.02

* Says for three months ended march 31, 2017, net revenues were $9.6 million, compared to $7.7 million

* Qtrly loss per share attributable to common shareholders $0.08 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below